Taiwan-based Formosa Pharmaceuticals (6838: TW) revealed that it has entered into an exclusive licensing agreement with Medvisis Switzerland, in Switzerland and Liechtenstein, for exclusive rights to ...

A 32-year-old man was fined S$266,500 in September 2024 for possessing and supplying 126 types of cosmetic products which ...

In what the HSA described in a Nov 27 statement as a “first-of-its-kind large-scale collaboration with online platform ...

The eight platforms are Amazon Singapore, Carousell, eBay Singapore, Facebook, Lazada, Qoo10, Shopee and TikTok.

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary ...

Three cosmetic products have been withdrawn from the market after it was deemed they all had "serious chemical risks." Makari ...

Avenue Capital agrees to Company’s deferral of principal and interest payments on its outstanding debt until the end of February 2025Eyenovia ...

EYEN stock craters on the decision to terminate late-stage myopia study of MicroPine following negative feedback from an ...

The analyst pointed out that while Eyenovia's pipeline and commercial products, including the newly launched clobetasol propionate ophthalmic solution 0.05%, hold value, the company's capital ...

Eyenovia’s stock craters to its lowest point in its six-year lifespan as a public company following the biotech’s termination ...

A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy endpoint Company to discontinue study, review full data set, and ...